Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma

Mace L. Rothenberg, Bonnie LaFleur, Donna E. Levy, Mary Kay Washington, Sherry L. Morgan-Meadows, Ramesh K. Ramanathan, Jordan D. Berlin, Al B. Benson, Robert J. Coffey

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences